Percutaneous
Stereotactic Radiofrequency Thermal
Rhizotomy for the Treatment of Trigeminal Neuralgia
{To
the Trigeminal Neuralgia Page with information and links regarding
hemifacial spasm, glossopharyngeal neuralgia, and trigeminal neuralgia.
}
Trigeminal
neuralgia, often called tic douloureux, is a craniofacial pain disorder
characterized by paroxysms of severe, sharp, lancinating, "electric-like",
bolts of pain. Trigeminal neuralgia is either classic / idiopathic
(primary) or due to a structural lesion involving the trigeminal system
(secondary). Classic / idiopathic trigeminal neuralgia typically occurs
in persons over the age of fifty, is more common in females, is predominately
unilateral, often has tactile "trigger" areas, and does
not produce sensory loss (numbness). The pain attacks can occur spontaneously
or can be triggered by a stimulus to the skin, intraoral mucosa and
very often the teeth. Many patients initially are evaluated by dentists,
oral and maxillofacial surgeons, primary care physicians and neurologists
before being referred to a major academic medical center with a multi-disciplinary
pain group.
The
Massachusetts General Hospital Departments of Neurological Surgery,
Oral and Maxillofacial Surgery and Anesthesiology have designed
a methodical approach to the diagnosis and treatment of craniofacial
pain disorders and in particular, trigeminal neuralgia. A comprehensive
medical evaluation is first performed including the appropriate
diagnostic testing. Imaging studies are employed to evaluate for
the presence of a tumor, blood vessel abnormality or multiple sclerosis
which might be damaging the trigeminal system. The first line of
treatment to help relieve the pain is usually medical therapy, with
drugs such as carbamazepine (Tegretol), baclofen (Lioresal), phenytoin
(Dilantin) or clonazepam (Klonopin). However, very often, these
medications do not eliminate the pain and / or can produce significant
side effects which can be disruptive to the functions of daily living
or could be potentially harmful. If medical therapy is unsuccessful,
surgical procedures can be performed to eliminate the pain.
Percutaneous
Stereotactic Differential Radiofrequency Thermal Rhizotomy is a
surgical procedure that was developed in the 1960's and has been
modified by physicians at the Massachusetts General Hospital for
the treatment of trigeminal neuralgia. This procedure creates a
precise thermal lesion of the trigeminal nerve which interrupts
the transmission of pain signals to the brain, while preserving
touch sensations of the face. Radiofrequency Thermal Rhizotomy does
produce some mild numbness of the face in the region of the pain,
which is usually quite tolerable. It does not effect the nerve function
to the muscles of the face, therefore facial paralysis is not a
concern.
Dr.
Ernest S. Mathews (Neurological Surgery), Dr. Steven J. Scrivani
(Oral and Maxillofacial Surgery), Dr.
Fred DeBros (Anesthesiology) and Mr. Terry Picard (Radiology)
perform this procedure with a technique which allows the surgeons
to perform nerve testing and thermal nerve lesioning with continuous
radiographic imaging and most importantly, maximum patient comfort.
This procedure is performed as outpatient day surgery; patients
are admitted on the morning of the procedure and can usually be
discharged by the early evening. Our patient series has successful
pain relief which is comparable to other centers in the country,
while experiencing minimal complications and side effects.
|